Compare CMI & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMI | GSK |
|---|---|---|
| Founded | 1919 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.3B | 96.1B |
| IPO Year | 1994 | N/A |
| Metric | CMI | GSK |
|---|---|---|
| Price | $581.73 | $59.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $566.67 | N/A |
| AVG Volume (30 Days) | 1.0M | ★ 6.2M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | 1.36% | ★ 3.02% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 20.50 | N/A |
| Revenue | ★ $33,670,000,000.00 | N/A |
| Revenue This Year | $7.18 | $6.75 |
| Revenue Next Year | $8.55 | $4.88 |
| P/E Ratio | ★ $28.68 | $32.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $260.02 | $32.38 |
| 52 Week High | $617.98 | $61.70 |
| Indicator | CMI | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 49.33 | 61.37 |
| Support Level | $502.75 | $47.89 |
| Resistance Level | $613.49 | $60.37 |
| Average True Range (ATR) | 16.59 | 0.83 |
| MACD | -3.11 | -0.36 |
| Stochastic Oscillator | 15.36 | 28.12 |
Cummins is a leading manufacturer of diesel and other engines used in heavy- and medium-duty commercial trucks, off-highway equipment, and locomotives, in addition to prime power and standby generators. The company also sells powertrain components, which include filtration products, transmissions, turbochargers, aftertreatment systems, and fuel systems. Sales are approximately 60% US and Canada and 40% rest of the world. Much of Cummins' foreign sales (China, India, and so forth) are through joint ventures. The company operates 650 distributors and over 19,000 dealer locations across 190 countries. Cummins' business model is unique as it competes with many of its heavy-duty truck manufacturer customers, which also make their own engines.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.